MedPath

Role of individualized homoeopathic medicine in Fibroadenoma of Breast.

Phase 2
Conditions
Health Condition 1: D249- Benign neoplasm of unspecified breast
Registration Number
CTRI/2024/08/072548
Lead Sponsor
Dr Barnali Dhara
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All the diagnosed cases of fibroadenoma of breast, either by clinically, sonographically or by needle biopsy will be taken up for the study .

2. Female patients belonging to reproductive age group .

3. Size of fibroadenoma in between 1-5 cm measured by USG- BIRADS.

4. Female patients who are free to give written consent for complete follow up during the study period.

5. Fibroadenoma of breast may be single, multiple and or bilateral.

Exclusion Criteria

1. Patients taking Oral contraceptive pills or any hormonal therapy .

2. Terminally ill patients or patients who are taking medicines for their chronic illness i.e. diabetes mellitus, hypertension, autoimmune diseases.

3. Pregnant women, women who conceived during the study period and lactating women.

4. USG-BIRADS scoring range more than category -3 or any suspicious case.

5. Breast lump with cyclical mastalgia .

6. Any inflammatory diseases of breast .

7. Other condition like fibrocystic disease of breast, phyllode, complex fibroadenoma of breast , giant ( juvenile) fibroadenoma .

8. History of laser or radiation therapy using in target breast.

9. Immune-compromised patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath